Takeda S, Hisatomi K, Nakano S, Okamoto K, Nagafuchi Y, Itoh H, Ohsato K
Department of Surgery, Kitakyushu Municipal Medical Center, Japan.
Surg Today. 1995;25(5):440-3. doi: 10.1007/BF00311823.
We treated a man with unresectable hepatic metastases from sigmoid colon carcinoma who has since survived for more than 10 years. A sigmoidectomy with lymph node dissection was performed and a continuous hepatic arterial infusion of 5-fluorouracil (5-FU) with intermittent infusion of mitomycin C (MMC) was administered for about 3 months after this operation. The total doses of 5-FU and MMC were 16 g and 84 mg, respectively. Tegafur also was administered orally at a dose of 600 mg/day for about 8 months. The carcinoembryonic antigen (CEA) level (which had reached 4,409 ng/ml preoperatively) normalized 4 months after surgery, and still remains normal. Very few patients with unresectable hepatic metastases survive for 5 or more years. However, regional chemotherapy can be effective in some patients.
我们治疗了一名患有无法切除的乙状结肠癌肝转移的男性患者,该患者已存活超过10年。进行了乙状结肠切除术及淋巴结清扫术,术后约3个月持续进行肝动脉输注5-氟尿嘧啶(5-FU)并间歇输注丝裂霉素C(MMC)。5-FU和MMC的总剂量分别为16 g和84 mg。替加氟也以每日600 mg的剂量口服给药约8个月。癌胚抗原(CEA)水平(术前已达4409 ng/ml)在术后4个月恢复正常,且至今仍保持正常。很少有无法切除的肝转移患者能存活5年或更长时间。然而,区域化疗对某些患者可能有效。